Bupropion SR Enhances Weight Loss: A 48-Week Double-Blind, Placebo- Controlled Trial
Dietary modifications should focus on evidence-based patterns recommended by NICE and Diabetes UK
Nausea, vomiting, diarrhea, constipation, pancreatitis symptoms, gallbladder problems, and potential thyroid concerns are the main issues discussed in clinical literature
Some people notice appetite changes quickly, while others need more time to adjust
To sum up, GLP-1 receptor agonists protect neurons through several pathways including the classic cAMP/PKA/CREB pathway, the PI3K/Akt pathway, controlling inflammation, and keeping mitochondria working as shown in Figure 1
These neuropods synapse and thus establish direct connections with vagal afferents, enteric glia, and efferent fibers, releasing neurotransmitters such as glutamate